Company news
Eton Pharmaceuticals, Inc. news in 2020
Eton Pharmaceuticals, Inc.'s news releases, calls and decks from 2020, newest first.
Eton Pharmaceuticals Announces Acceptance for Filing of New Drug Application for Topiramate Oral Solution
December 16, 2020
Eton Pharmaceuticals Announces Availability of Orphan Drug ALKINDI® SPRINKLE (hydrocortisone) in the United States
November 23, 2020
Eton Pharmaceuticals Announces Third Quarter 2020 Financial Results
November 11, 2020
Eton Pharmaceuticals to Report Third Quarter Financial Results on Thursday, November 12, 2020
November 3, 2020
Eton Pharmaceuticals Announces Closing of Public Offering
October 15, 2020
Eton Pharmaceuticals Announces Acceptance for Filing of New Drug Application for Zonisamide Oral Suspension
October 14, 2020
Eton Pharmaceuticals Prices Underwritten Public Offering of Common Stock
October 13, 2020
Eton Pharmaceuticals Announces Proposed Public Offering of Common Stock
October 12, 2020
Eton Pharmaceuticals Announces Acceptance for Filing of New Drug Application for Orphan Drug Dehydrated Alcohol Injection
October 7, 2020
Eton Pharmaceuticals Submits New Drug Application to the FDA for Topiramate Oral Solution (ET-101)
October 5, 2020
Eton Pharmaceuticals Announces FDA Approval of Orphan Drug ALKINDI® SPRINKLE (hydrocortisone) as Replacement Therapy in Pediatric Patients with Adrenocortical Insufficiency
September 28, 2020
Eton Pharmaceuticals Provides Update on the FDA Review of EM-100
September 15, 2020
Eton Pharmaceuticals Announces Appointment of Ingrid Hoos as Senior Vice President of Scientific Affairs
August 30, 2020
Eton Pharmaceuticals Announces Second Quarter 2020 Financial Results
August 11, 2020
Eton Pharmaceuticals to Report Second Quarter Financial Results on Wednesday, August 12, 2020
August 3, 2020
Eton Pharmaceuticals Submits New Drug Application to the FDA for Zonisamide Oral Suspension (ET-104)
July 29, 2020
Eton Pharmaceuticals Submits New Drug Application to the FDA for Orphan Drug Dehydrated Alcohol Injection (DS-100)
July 26, 2020
Eton Pharmaceuticals Announces First Quarter 2020 Financial Results
May 13, 2020
Eton Pharmaceuticals Confirms First-to-File Patent Challenge on Elcys (Cysteine Hydrochloride Injection)
May 6, 2020
Eton Pharmaceuticals to Report First Quarter Financial Results on Thursday, May 14, 2020
May 5, 2020
Eton Pharmaceuticals Announces Appointment of Paul Stickler as Senior Vice President of Sales and Marketing
May 3, 2020
Eton Pharmaceuticals Announces Acquisition of U.S Marketing Rights to Pediatric Orphan Drug Alkindi® Sprinkle
March 26, 2020
Eton Pharmaceuticals Reports Positive Study Results for ET-101 (Topiramate Oral Solution)
March 16, 2020
Eton Pharmaceuticals Announces Fourth Quarter and Full Year 2019 Financial Results
March 4, 2020
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2019 Financial Results on Thursday, March 5, 2020
February 26, 2020
Eton Pharmaceuticals Provides Update on ET-105 Program
February 18, 2020
Eton Pharmaceuticals to Present at the 9th Annual SVB Leerink Healthcare Conference
February 12, 2020
Eton Pharmaceuticals and Xellia Pharmaceuticals Announce Biorphen® (phenylephrine HCl) Co-Promotion Agreement
January 20, 2020